Bayer AG (BAYN) PT Set at €103.00 by BNP Paribas
Bayer AG (FRA:BAYN) has been assigned a €103.00 ($122.62) price objective by investment analysts at BNP Paribas in a research report issued to clients and investors on Wednesday. The brokerage currently has a “neutral” rating on the healthcare company’s stock.
Several other equities analysts have also recently commented on BAYN. UBS AG set a €125.00 ($148.81) target price on shares of Bayer AG and gave the company a “buy” rating in a research report on Friday, May 12th. Jefferies Group LLC set a €145.00 ($172.62) target price on shares of Bayer AG and gave the company a “buy” rating in a research report on Monday, May 15th. DZ Bank AG restated a “neutral” rating on shares of Bayer AG in a research report on Saturday, May 20th. Sanford C. Bernstein set a €128.00 ($152.38) target price on shares of Bayer AG and gave the company a “buy” rating in a research report on Monday, May 22nd. Finally, Independent Research GmbH set a €123.00 ($146.43) target price on shares of Bayer AG and gave the company a “neutral” rating in a research report on Wednesday, June 7th. Nine investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of €119.55 ($142.32).
Shares of Bayer AG (FRA:BAYN) traded down 0.544% during mid-day trading on Wednesday, reaching €108.747. 2,727 shares of the company’s stock traded hands. The stock has a market cap of €94.84 billion and a PE ratio of 18.811. Bayer AG has a 12 month low of €85.72 and a 12 month high of €123.83. The firm has a 50 day moving average price of €108.03 and a 200-day moving average price of €111.06.
About Bayer AG
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.